Skip to main content
SpringerLink
Log in

The primary arteriovenous fistula failure—a comparison between diabetic and non-diabetic patients: glycemic control matters

  • Nephrology – Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Objectives

Presence of diabetes mellitus has been shown to be related with the occurrence of primary arteriovenous fistula (AVF) failure in some but not in all studies. In the current study, we examined whether glycemic control as evaluated by HbA1c is independently related with primary AVF failure.

Methods

We recorded sociodemographic, clinical, and laboratory parameters of the patients from medical records and hospital charts prior to AVF surgery. Primary AVF failure was described as a complication of the AVF before the first successful cannulation for HD treatment.

Results

Our study comprised of 160 non-diabetic (Group1) and 73 diabetic patients. Among diabetic patients, 37 had HbA1c values <7% (Group 2) and 36 patients had HbA1c values ≥7% (Group 3). In total, 74 (31.8%) patients had a history of primary AVF failure. The percentages of primary AVF failure were 27.5, 29.7, and 52.8% in Group 1, Group 2, and Group 3, respectively (P: 0.013). The percentage of patients with primary AVF failure was significantly lower in Group 1 and Group 2 than in Group 3 (P:0.003 and P:0.045, respectively). There was no difference with respect to primary AVF failure between Group 1 and Group 2 patients.

Conclusions

We suggest that poor glycemic control as assessed by HbA1c may be an important factor for the development of primary AVF failure among diabetic subjects. It is possible that differences with respect to AVF failure between diabetic and non-diabetic patients may be partly attributed to glycemic control.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Allon M, Robbin ML (2002) Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int 62:1109–1124

    Article  PubMed  Google Scholar 

  2. Polkinghorne KR, McDonald SP, Atkins RC et al (2004) Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol 15:477–486

    Article  PubMed  Google Scholar 

  3. Dember LM, Beck GJ, Allon M et al (2008) Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA 299:2164–2171

    Article  PubMed  CAS  Google Scholar 

  4. Asif A, Roy-Chaudhury P, Beathard GA (2006) Early arteriovenous fistula failure: a logical proposal for when and how to intervene. Clin J Am Soc Nephrol 1:332–339

    Article  PubMed  Google Scholar 

  5. Robbin ML, Chamberlain NE, Lockhart ME et al (2002) Hemodialysis arteriovenous fistula maturity: US evaluation. Radiology 225:59–64

    Article  PubMed  Google Scholar 

  6. Huijbregts HJ, Bots ML, Wittens CH et al (2008) Hemodialysis arteriovenous fistula patency revisited: results of a prospective multicenter initiative. Clin J Am Soc Nephrol 3:714–719

    Article  PubMed  Google Scholar 

  7. Lin SL, Huang CH, Chen HS et al (1998) Effects of age and diabetes on blood flow rate and primary outcome of newly created hemodialysis arteriovenous fistulas. Am J Nephrol 18:96–100

    Article  PubMed  CAS  Google Scholar 

  8. Murphy GJ, Saunders R, Metcalfe M et al (2002) Elbow fistulas using autogeneous vein: patency rates and results of revision. Postgrad Med J 78:483–486

    Article  PubMed  CAS  Google Scholar 

  9. Manns BJ, Burgess ED, Parsons HG et al (1999) Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients. Kidney Int 55:315–320

    Article  PubMed  CAS  Google Scholar 

  10. Konner K (2000) Primary vascular access in diabetic patients: an audit. Nephrol Dial Transplant 15:1317–1325

    Article  PubMed  CAS  Google Scholar 

  11. Windus DW (1993) Permanent vascular access: a nephrologist’s view. Am J Kidney Dis 21:457–471

    PubMed  CAS  Google Scholar 

  12. Giugliano D, Ceriello A, Esposito K (2008) Glucose metabolism and hyperglycemia. Am J Clin Nutr 87:217S–222S

    PubMed  CAS  Google Scholar 

  13. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group (1998) Lancet 352: 837–53

  14. Nathan DM, Cleary PA, Backlund JY et al (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643–2653

    Article  PubMed  Google Scholar 

  15. Willfort-Ehringer A, Ahmadi R, Gessl A et al (2004) Neointimal proliferation within carotid stents is more pronounced in diabetic patients with initial poor glycaemic state. Diabetologia 47:400–406

    Article  PubMed  CAS  Google Scholar 

  16. Osende JI, Badimon JJ, Fuster V et al (2001) Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control. J Am Coll Cardiol 38:1307–1312

    Article  PubMed  CAS  Google Scholar 

  17. Guo LX, Pan Q, Wang XX et al (2008) Effect of short term intensive multi-therapy on carotid intima-media thickness in patients with newly diagnosed type 2 diabetes mellitus. Chin Med J (Engl) 121:687–690

    CAS  Google Scholar 

  18. Kawasumi M, Tanaka Y, Uchino H et al (2006) Strict glycemic control ameliorates the increase of carotid IMT in patients with type 2 diabetes. Endocr J 53:45–50

    Article  PubMed  Google Scholar 

  19. Huijbregts HJ, Bots ML, Moll FL et al (2007) Hospital specific aspects predominantly determine primary failure of hemodialysis arteriovenous fistulas. J Vasc Surg 45:962–967

    Article  PubMed  Google Scholar 

  20. Mathew V, Gersh BJ, Williams BA et al (2004) Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation 109:476–480

    Article  PubMed  Google Scholar 

  21. Berceli SA, Davies MG, Kenagy RD et al (2002) Flow induced neointimal regression in baboon polytetrafluoroethylene grafts is associated with decreased cell proliferation and increased apoptosis. J Vasc Surg 36:1248–1255

    Article  PubMed  Google Scholar 

  22. Qin F, Dardik H, Pangilinan A, Robinson J, Chuy J, Wengerter K (2001) Remodeling and suppression of intimal hyperplasia of vascular grafts with a distal arteriovenous fistula in a rat model. J Vasc Surg 34:701–706

    Article  PubMed  CAS  Google Scholar 

  23. Steffen LM, Duprez DA, Boucher JL et al (2008) Management of peripheral arterial disease. Diabetes Spectr 21:171–177

    Article  Google Scholar 

  24. Selvin E, Marinopoulos S, Berkenblit G et al (2004) Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141:421–431

    PubMed  CAS  Google Scholar 

  25. Lakatta EG (2003) Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part III: cellular and molecular clues to heart and arterial aging. Circulation 107:490–497

    Article  PubMed  Google Scholar 

  26. Hadi HA, Suwaidi JA (2007) Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag 3:853–876

    PubMed  CAS  Google Scholar 

  27. Spinetti G, Kraenkel N, Emanueli C et al (2008) Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies. Cardiovasc Res 78:265–273

    Article  PubMed  CAS  Google Scholar 

  28. Kaufman JS, O’Connor TZ, Zhang JH et al (2003) Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J Am Soc Nephrol 14:2313–2321

    Article  PubMed  CAS  Google Scholar 

  29. Hasegawa T, Elder SJ, Bragg-Gresham JL et al (2008) Consistent aspirin use associated with improved arteriovenous fistula survival among incident hemodialysis patients in the dialysis outcomes and practice patterns study. Clin J Am Soc Nephrol 3:1373–1378

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Nephrology, Zonguldak Atatürk State Hospital, Mesrutiyet Mah, Mustafa türkcelik Sok, Büsra Sitesi C Blok, 67100, Zonguldak, Turkey

    Baris Afsar & Rengin Elsurer

Authors
  1. Baris Afsar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rengin Elsurer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Baris Afsar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Afsar, B., Elsurer, R. The primary arteriovenous fistula failure—a comparison between diabetic and non-diabetic patients: glycemic control matters. Int Urol Nephrol 44, 575–581 (2012). https://doi.org/10.1007/s11255-011-9978-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-011-9978-x

Keywords

Search

Navigation